Paper38136994
Molecular Characterization and Establishment of a Prognostic Model Based on Primary Immunodeficiency Features in Association with RNA Modifications in Triple-Negative Breast Cancer.
Xia H and 5 others. Genes (Basel), 2023. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Molecular Characterization and Establishment of a Prognostic Model Based on Primary Immunodeficiency Features in Association with RNA Modifications in Triple-Negative Breast Cancer. Papers, record 38136994. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38136994
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Molecular Characterization and Establishment of a Prognostic Model Based on Primary Immunodeficiency Features in Association with RNA Modifications in Triple-Negative Breast Cancer.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Triple Negative Breast Neoplasms | Major topic |
| Humans | |
| Prognosis | |
| Nomograms | |
| Up-Regulation | |
| RNA |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82103342 | National Natural Science Foundation of China | PubMed | ||
| 82173374 | National Natural Science Foundation of China | PubMed | ||
| 2021JJ40366 | Natural Science Foundation of Hunan Province | PubMed |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20808728 | Regularization Paths for Generalized Linear Models via Coordinate Descent. | J Stat Softw | 2010 | https://conductscience.org/library/papers/20808728 | PubMed |
| 2 | 36038913 | Recent advances in therapeutic strategies for triple-negative breast cancer. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/36038913 | PubMed |
| 3 | 34260682 | oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. | Brief Bioinform | 2021 | https://conductscience.org/library/papers/34260682 | PubMed |
| 4 | 34986603 | m5C-Atlas: a comprehensive database for decoding and annotating the 5-methylcytosine (m5C) epitranscriptome. | Nucleic Acids Res | 2022 | https://conductscience.org/library/papers/34986603 | PubMed |
| 5 | 22236430 | DNA repair: the link between primary immunodeficiency and cancer. | Ann N Y Acad Sci | 2011 | https://conductscience.org/library/papers/22236430 | PubMed |
| 6 | 32300195 | Role of RNA modifications in cancer. | Nat Rev Cancer | 2020 | https://conductscience.org/library/papers/32300195 | PubMed |
| 7 | 23323831 | GSVA: gene set variation analysis for microarray and RNA-seq data. | BMC Bioinformatics | 2013 | https://conductscience.org/library/papers/23323831 | PubMed |
| 8 | 36499265 | Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36499265 | PubMed |
| 9 | 24113773 | Inferring tumour purity and stromal and immune cell admixture from expression data. | Nat Commun | 2013 | https://conductscience.org/library/papers/24113773 | PubMed |
| 10 | 33813687 | Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC). | Breast Cancer | 2021 | https://conductscience.org/library/papers/33813687 | PubMed |
| 11 | 30679171 | Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment. | Cancer Discov | 2019 | https://conductscience.org/library/papers/30679171 | PubMed |
| 12 | 35429629 | Primary sequence-assisted prediction of m6A RNA methylation sites from Oxford nanopore direct RNA sequencing data. | Methods | 2022 | https://conductscience.org/library/papers/35429629 | PubMed |
| 13 | 27939063 | Molecular alterations in triple-negative breast cancer-the road to new treatment strategies. | Lancet | 2017 | https://conductscience.org/library/papers/27939063 | PubMed |
| 14 | 36428620 | A Novel m7G-Related Gene Signature Predicts the Prognosis of Colon Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36428620 | PubMed |
| 15 | 37351345 | Editorial: RNA modifications and epitranscriptomics, Volume II. | Front Genet | 2023 | https://conductscience.org/library/papers/37351345 | PubMed |
| 16 | 32499645 | Whole-genome sequencing of a sporadic primary immunodeficiency cohort. | Nature | 2020 | https://conductscience.org/library/papers/32499645 | PubMed |
| 17 | 34093853 | N-cadherin mediates the migration of bone marrow-derived mesenchymal stem cells toward breast tumor cells. | Theranostics | 2021 | https://conductscience.org/library/papers/34093853 | PubMed |
| 18 | 37587690 | m6A-Atlas v2.0: updated resources for unraveling the N6-methyladenosine (m6A) epitranscriptome among multiple species. | Nucleic Acids Res | 2024 | https://conductscience.org/library/papers/37587690 | PubMed |
| 19 | 36062570 | RMDisease V2.0: an updated database of genetic variants that affect RNA modifications with disease and trait implication. | Nucleic Acids Res | 2023 | https://conductscience.org/library/papers/36062570 | PubMed |
| 20 | 31057537 | A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity). | Front Immunol | 2019 | https://conductscience.org/library/papers/31057537 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40496561 | Identification and validation of prognostic genes associated with T-cell exhaustion and macrophage polarization in breast cancer. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40496561 | PubMed |
| 40223933 | Integrative analysis of anti-breast CancerPotential of metabolites from Pseudomonas frederiksbergensis isolated from Taoerqi. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40223933 | PubMed |
Genes53
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38136994
GET https://conductscience.org/api/papers/v1/38136994/references?page=2